Amedeo's Top 20

Amedeo Smart

Independent Medical Education


23 September 2019

Multidisciplinary Journal Club

  1. Xu L, Wang J, Liu Y, Xie L, et al.
    CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
    N Engl J Med 2019.

  1. Paton DG, Childs LM, Itoe MA, Holmdahl IE, et al.
    Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission.
    Nature 2019;567:239-243.

  2. Stahl A, Lepore D, Fielder A, Fleck B, et al.
    Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.
    Lancet 2019.

  3. Rosenwald A, Bens S, Advani R, Barrans S, et al.
    Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
    J Clin Oncol 2019.

  4. Kim HA, Lee JW, Nam SJ, Park BW, et al.
    Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
    J Clin Oncol 2019.

  1. Capella C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, et al.
    Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
    J Infect Dis 2017;216:1398-1406.

  2. Tayal B, Fruelund P, Sogaard P, Riahi S, et al.
    Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study.
    Eur Heart J 2019.

  3. Magliano DJ, Islam RM, Barr ELM, Gregg EW, et al.
    Trends in incidence of total or type 2 diabetes: systematic review.
    BMJ 2019;366:l5003.

  4. Ampuero J, Jimeno C, Quiles R, Rosales JM, et al.
    Impact of comorbidities on patients outcomes after interferon-free therapy-induced viral eradication in hepatitis.
    J Hepatol 2017.

  5. Ryom L, Lundgren JD, Reiss P, Kirk O, et al.
    Use of contemporary protease inhibitors and risk of incident chronic kidney disease in HIV-positive persons; the D:A:D Study.
    J Infect Dis 2019.

  1. Eisinger RW, Erbelding E, Fauci AS.
    Refocusing Research on Sexually Transmitted Infections.
    J Infect Dis 2019.

  2. Godinho-Santos A, Foxall RB, Antao AV, Tavares B, et al.
    Follicular helper T cells are major HIV-2 reservoirs and support productive infection.
    J Infect Dis 2019.

  3. Molnar AO, Petrcich W, Weir MA, Garg AX, et al.
    The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.
    Nephrol Dial Transplant 2019.

  4. Lallas A, Apalla Z, Kyrgidis A, Papageorgiou C, et al.
    Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring.
    J Am Acad Dermatol 2019.

  5. Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, et al.
    Long-term Outcomes and Cost-effectiveness of Breast Cancer Screening with Digital Breast Tomosynthesis in the United States.
    J Natl Cancer Inst 2019.

  1. Kosloski MP, Oberoi R, Wang S, Viani RM, et al.
    Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered with Human Immunodeficiency Virus Antiretrovirals.
    J Infect Dis 2019.

  2. Pieske B, Tschope C, de Boer RA, Fraser AG, et al.
    How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    Eur Heart J 2019.

  3. Selvaraj S, Claggett B, Pozzi A, McMurray JJV, et al.
    Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients with Heart Failure and Reduced Ejection Fraction:PARADIGM-HF.
    Circulation 2019.

  4. Dugre JR, Bitar N, Dumais A, Potvin S, et al.
    Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind.
    Am J Psychiatry 2019.

  5. Kahaly GJ, Stan MN, Frommer L, Gergely P, et al.
    A Novel Anti-Cd40 Monoclonal Antibody, Iscalimab, for Control of Graves' Hyperthyroidism - A Proof-Of-Concept Trial.
    J Clin Endocrinol Metab 2019.


more..


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016